GH logo

Guardant Health, Inc. (GH) Selling, General & Administrative Expenses

Annual SG&A:

$545.06M+$94.03M(+20.85%)
December 31, 2024

Summary

  • As of today, GH annual SG&A is $545.06 million, with the most recent change of +$94.03 million (+20.85%) on December 31, 2024.
  • During the last 3 years, GH annual SG&A has risen by +$146.54 million (+36.77%).
  • GH annual SG&A is now at all-time high.

Performance

GH SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

Quarterly SG&A:

$180.64M+$10.79M(+6.36%)
September 30, 2025

Summary

  • As of today, GH quarterly SG&A is $180.64 million, with the most recent change of +$10.79 million (+6.36%) on September 30, 2025.
  • Over the past year, GH quarterly SG&A has increased by +$33.63 million (+22.88%).
  • GH quarterly SG&A is now at all-time high.

Performance

GH Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

TTM SG&A:

-$10.89B-$398.79M(-3.80%)
September 30, 2025

Summary

  • As of today, GH TTM SG&A is -$10.89 billion, with the most recent change of -$398.79 million (-3.80%) on September 30, 2025.
  • Over the past year, GH TTM SG&A has dropped by -$11.40 billion (-2255.74%).
  • GH TTM SG&A is now -5464.10% below its all-time high of -$195.74 million.

Performance

GH TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGHincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

GH Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+20.9%+22.9%-2255.7%
3Y3 Years+36.8%+48.7%-2551.0%
5Y5 Years+290.1%+97.7%-4644.8%

GH Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+36.8%at high+71.9%-116.9%at low
5Y5-Yearat high+290.1%at high+97.7%-547.7%at low
All-TimeAll-Timeat high+1409.3%at high+1354.9%-5464.1%at low

GH Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$180.64M(+6.4%)
$658.40M(+5.4%)
Jun 2025
-
$169.85M(+12.3%)
$624.77M(+8.2%)
Mar 2025
-
$151.27M(-3.4%)
$577.25M(+5.9%)
Dec 2024
$545.06M(+20.8%)
$156.64M(+6.6%)
$545.06M(+7.9%)
Sep 2024
-
$147.01M(+20.2%)
$505.21M(+9.0%)
Jun 2024
-
$122.33M(+2.7%)
$463.31M(+2.2%)
Mar 2024
-
$119.08M(+2.0%)
$453.54M(+0.6%)
Dec 2023
$451.03M(-2.8%)
$116.79M(+11.1%)
$451.03M(-0.6%)
Sep 2023
-
$105.11M(-6.6%)
$453.55M(-3.5%)
Jun 2023
-
$112.56M(-3.4%)
$469.93M(-1.0%)
Mar 2023
-
$116.57M(-2.3%)
$474.65M(+2.3%)
Dec 2022
$463.78M(+16.4%)
$119.31M(-1.8%)
$463.78M(+4.4%)
Sep 2022
-
$121.49M(+3.6%)
$444.35M(+5.0%)
Jun 2022
-
$117.28M(+11.0%)
$423.14M(+5.3%)
Mar 2022
-
$105.70M(+5.8%)
$401.95M(+0.9%)
Dec 2021
$398.52M
$99.87M(-0.4%)
$398.52M(-0.2%)
Sep 2021
-
$100.28M(+4.4%)
$399.44M(+2.3%)
Jun 2021
-
$96.09M(-6.0%)
$390.55M(+9.5%)
DateAnnualQuarterlyTTM
Mar 2021
-
$102.27M(+1.5%)
$356.66M(+19.2%)
Dec 2020
$299.28M(+114.2%)
$100.79M(+10.3%)
$299.28M(+24.9%)
Sep 2020
-
$91.39M(+46.9%)
$239.64M(+30.6%)
Jun 2020
-
$62.20M(+38.5%)
$183.49M(+19.0%)
Mar 2020
-
$44.90M(+9.1%)
$154.17M(+10.3%)
Dec 2019
$139.73M(+55.9%)
$41.15M(+16.8%)
$139.73M(+9.0%)
Sep 2019
-
$35.24M(+7.2%)
$128.25M(+11.9%)
Jun 2019
-
$32.88M(+7.9%)
$114.60M(+12.0%)
Mar 2019
-
$30.47M(+2.7%)
$102.29M(+14.1%)
Dec 2018
$89.66M(+29.4%)
$29.66M(+37.4%)
$89.66M(+14.4%)
Sep 2018
-
$21.59M(+5.0%)
$78.35M(-2.9%)
Jun 2018
-
$20.57M(+15.4%)
$80.66M(+8.0%)
Mar 2018
-
$17.83M(-2.8%)
$74.69M(+7.8%)
Dec 2017
$69.27M(+91.8%)
$18.35M(-23.2%)
$69.27M(+36.0%)
Sep 2017
-
$23.90M(+63.7%)
$50.92M(+88.5%)
Jun 2017
-
$14.60M(+17.6%)
$27.02M(+117.6%)
Mar 2017
-
$12.42M
$12.42M
Dec 2016
$36.11M
-
-

FAQ

  • What is Guardant Health, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Guardant Health, Inc.?
  • What is Guardant Health, Inc. annual SG&A year-on-year change?
  • What is Guardant Health, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Guardant Health, Inc.?
  • What is Guardant Health, Inc. quarterly SG&A year-on-year change?
  • What is Guardant Health, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Guardant Health, Inc.?
  • What is Guardant Health, Inc. TTM SG&A year-on-year change?

What is Guardant Health, Inc. annual SG&A?

The current annual SG&A of GH is $545.06M

What is the all-time high annual SG&A for Guardant Health, Inc.?

Guardant Health, Inc. all-time high annual SG&A is $545.06M

What is Guardant Health, Inc. annual SG&A year-on-year change?

Over the past year, GH annual SG&A has changed by +$94.03M (+20.85%)

What is Guardant Health, Inc. quarterly SG&A?

The current quarterly SG&A of GH is $180.64M

What is the all-time high quarterly SG&A for Guardant Health, Inc.?

Guardant Health, Inc. all-time high quarterly SG&A is $180.64M

What is Guardant Health, Inc. quarterly SG&A year-on-year change?

Over the past year, GH quarterly SG&A has changed by +$33.63M (+22.88%)

What is Guardant Health, Inc. TTM SG&A?

The current TTM SG&A of GH is -$10.89B

What is the all-time high TTM SG&A for Guardant Health, Inc.?

Guardant Health, Inc. all-time high TTM SG&A is -$195.74M

What is Guardant Health, Inc. TTM SG&A year-on-year change?

Over the past year, GH TTM SG&A has changed by -$11.40B (-2255.74%)
On this page